Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Experimental Neurology|February 23, 2000
Is Fos protein expressed by dying striatal neurons after immature hypoxic-ischemic brain injury?D E Oorschot, M J Black, F Rangi, et al.Bipolar Disorders|March 18, 2006
Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorderE Scarr, L Gray, D Keriakous, et al.Neurochemical Research|February 1, 1994
The effects of monoamine oxidase B inhibition on dopamine metabolism in rats with nigro-striatal lesionsE Scarr, D M Wingerchuk, A V Juorio, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1991
Studies on the properties of some peripheral MAO inhibitorsE Scarr, P H Yu, B A Davis, et al.Life Sciences|August 28, 2001
Extended treatment with typical and atypical antipsychotic drugs differential effects on the densities of dopamine D2-like and GABAA receptors in rat striatumB Dean, T Hussain, E Scarr, et al.Journal of Affective Disorders|December 24, 2008
Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjectsA S Gibbons, E Scarr, C McLean, et al.Life Sciences|April 15, 2004
Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophreniaB Dean, G Pavey, E Scarr, et al.Molecular Psychiatry|March 1, 2003
Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorderE A Thomas, B Dean, E Scarr, et al.Molecular Psychiatry|March 5, 2008
Decreased cortical muscarinic receptors define a subgroup of subjects with schizophreniaE Scarr, T F Cowie, S Kanellakis, et al.British Journal of Pharmacology|December 1, 1994
The effects of administration of monoamine oxidase-B inhibitors on rat striatal neurone responses to dopamineM D Berry, E Scarr, M Y Zhu, et al.Pageof 3